Stomatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with head and neck cancer; patients undergoing radiation therapy with or without associated chemotherapy; patients over 18 years of age, from both sexes
Exclusion criteria
Exclusion criteria: Patients with metastasis; latients undergoing radiotherapy as palliative care; patients with allergies to propolis or any substance contained in the spray formula; patients unable to complete the questionnaires or in a serious condition that prevents them from participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the use of the propolis spray will reduce the incidence and severity of oral mucositis, significantly improving the quality of life of patients undergoing radiotherapy. In addition, lower hospitalization rates and reduced analgesic use are anticipated, leading to decreased healthcare costs. The use of a natural, affordable, and low-cost product may enhance treatment adherence. The expected impact includes fewer clinical and social complications associated with the disease. Thus, this study may contribute to effective, safe, and sustainable therapeutic alternatives. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Universidade Federal de Pernambuco